130 related articles for article (PubMed ID: 35184607)
1. Delivery Outcomes Among Pregnant Women With Comorbid Psychiatric and Substance Use Disorders Receiving Comprehensive Treatment.
Seger C; Tuten M; Storr CL; Majer JM
J Am Psychiatr Nurses Assoc; 2024; 30(1):121-131. PubMed ID: 35184607
[No Abstract] [Full Text] [Related]
2. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
[TBL] [Abstract][Full Text] [Related]
3. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Antenatal Maternal Self-reported Substance Use, Maternal Characteristics, and Obstetrical Variables.
Berra A; Kamo S; Mohnot S; Rosselot J; Suire A; Stafford J; Hagan J; Stafford I
J Addict Med; 2019; 13(6):464-469. PubMed ID: 31033670
[TBL] [Abstract][Full Text] [Related]
5. Treatment of substance abuse during pregnancy and infant outcome.
Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey.
Roberts RE; Roberts CR; Xing Y
Drug Alcohol Depend; 2007 Apr; 88 Suppl 1(Suppl 1):S4-13. PubMed ID: 17275212
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcomes among adolescent and older women receiving comprehensive prenatal care.
Leppert PC; Namerow PB; Barker D
J Adolesc Health Care; 1986 Mar; 7(2):112-7. PubMed ID: 3957748
[TBL] [Abstract][Full Text] [Related]
8. The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics.
Kelly R; Zatzick D; Anders T
Am J Psychiatry; 2001 Feb; 158(2):213-9. PubMed ID: 11156803
[TBL] [Abstract][Full Text] [Related]
9. Neonatal outcomes of pregnant women attending integrated and standard substance use treatment programs in Ontario, Canada.
Milligan K; Tarasoff LA; Rodrigues ER; Iwajomo T; Gomes T; de Oliveira C; Brown HK; Urbanoski KA
Birth; 2024 Jun; 51(2):284-294. PubMed ID: 37983747
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Analysis of Oxcarbazepine in Pregnant Women With Substance Use Disorders: Focus on Safety.
Johnson KD; Miller LN; Pouliot JD; Martin PR
J Pharm Pract; 2021 Feb; 34(1):28-34. PubMed ID: 31232158
[TBL] [Abstract][Full Text] [Related]
11. Demographic and psychosocial characteristics of substance-abusing pregnant women.
Hans SL
Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of comorbid substance use and psychiatric disorders in Asia.
Thirthalli J; Kumar CN; Arunachal G
Curr Opin Psychiatry; 2012 May; 25(3):172-80. PubMed ID: 22449763
[TBL] [Abstract][Full Text] [Related]
13. The relationship between child abuse and negative outcomes among substance users: psychopathology, health, and comorbidities.
Banducci AN; Hoffman E; Lejuez CW; Koenen KC
Addict Behav; 2014 Oct; 39(10):1522-7. PubMed ID: 24976457
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of treatment for drug-abusing pregnant women.
Svikis DS; Golden AS; Huggins GR; Pickens RW; McCaul ME; Velez ML; Rosendale CT; Brooner RK; Gazaway PM; Stitzer ML; Ball CE
Drug Alcohol Depend; 1997 Apr; 45(1-2):105-13. PubMed ID: 9179512
[TBL] [Abstract][Full Text] [Related]
15. Substance use in pregnancy.
Wong S; Ordean A; Kahan M; ; ; ; ;
J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive treatment program for pregnant substance users in a family medicine clinic.
Ordean A; Kahan M
Can Fam Physician; 2011 Nov; 57(11):e430-5. PubMed ID: 22084472
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of substance use disorder among pregnant women in three state Medicaid programs from 2013 to 2016.
Lynch V; Clemans-Cope L; Howell E; Hill I
J Subst Abuse Treat; 2021 May; 124():108265. PubMed ID: 33771273
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009-2014.
Shen Y; Lo-Ciganic WH; Segal R; Goodin AJ
J Psychosom Obstet Gynaecol; 2020 Feb; ():1-7. PubMed ID: 32067526
[No Abstract] [Full Text] [Related]
19. Socioeconomic characteristics of women with substance use disorder during pregnancy and neonatal outcomes in their newborns: A national registry study from the Czech Republic.
Mravčík V; Nechanská B; Gabrhelík R; Handal M; Mahic M; Skurtveit S
Drug Alcohol Depend; 2020 Apr; 209():107933. PubMed ID: 32109712
[TBL] [Abstract][Full Text] [Related]
20. Treatment for substance use disorders in pregnant women: Motivators and barriers.
Frazer Z; McConnell K; Jansson LM
Drug Alcohol Depend; 2019 Dec; 205():107652. PubMed ID: 31704383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
